arrow
M

Murray B. Resnick

Rhode Island Hospital
H指数:52
被引数:9,732

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis

基于AI的病理学工具对代谢功能障碍相关的脂肪性肝炎进行评分的临床验证

2024-11-040
OAAI
Validation of a whole slide image management system for metabolic-associated steatohepatitis for clinical trials

用于代谢相关脂肪性肝炎临床试验的全载玻片图像管理系统的验证

2024-09-182
OAAI
AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases

基于AI的肝病临床试验中纳入标准和终点评估的自动化

2024-08-074
OAAI
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study

临床试验中病理学家小组在NASH组织学评分中达成共识的效用: 来自一项3期研究的数据

2024-01-015
OAAI
Integration of deep learning-based histopathology and transcriptomics reveals key genes associated with fibrogenesis in patients with advanced NASH

基于深度学习的组织病理学和转录组学的整合揭示了与晚期NASH患者纤维化相关的关键基因

2023-04-019
OAAI
AI-based quantitation of cancer cell and fibroblast nuclear morphology reflects transcriptomic heterogeneity and predicts survival in breast cancer
2023-03-010
PRE
A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis

用于肝组织学评估的机器学习方法可预测NASH肝硬化中具有临床意义的门静脉高压

2021-12-0126
OAAI
A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH

机器学习方法可以定量测量NASH中的肝脏组织学和疾病监测

2021-06-24110
OAAI
Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypes

来自密集映射的癌症病理幻灯片的人类可解释的图像特征预测了不同的分子表型

2021-03-12130
OAAI
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH

包括Cilofexor和Firsocostat在内的联合疗法可桥接NASH引起的纤维化和肝硬化

2021-02-15185
PREAI
Smooth muscle tumors of the gastrointestinal tract: an analysis of prognostic features in 407 cases
2020-07-0116
OAAI